• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

十字路口的关怀：应对艾滋病毒、丙型肝炎病毒和药物滥用共病问题

Care at the Crossroads: Navigating the HIV, HCV, and Substance Abuse Syndemic.

作者信息

Reece Rebecca, Dugdale Caitlin, Touzard-Romo Francine, Noska Amanda, Flanigan Timothy, Rich Josiah D

机构信息

Dr. Reece, Dr. Touzard-Romo, Dr. Noska, Dr. Flanigan, and Dr. Rich work in the Department of Medicine, Division of Infectious Disease, Warren Alpert Medical School of Brown University, Providence, Rhode Island. Dr. Dugdale works in the Department of Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island. Dr. Flanigan and Dr. Rich also work at the Center for Prisoner Health and Human Rights at the Miriam Hospital, Providence, Rhode Island.

出版信息

Fed Pract. 2014 Feb;31:37S-40S.

PMID:25520548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4266471/
Abstract

For patients with both HIV/HCV coinfection and substance addiction, multidisciplinary teams can facilitate coordination of care and improve clinical outcomes. Such teams should include HIV/HCV treatment providers, mental health specialists, case managers, social workers, and substance abuse counselors.

摘要

对于同时感染艾滋病毒/丙型肝炎病毒且有药物成瘾问题的患者，多学科团队可以促进护理协调并改善临床结果。这样的团队应包括艾滋病毒/丙型肝炎病毒治疗提供者、心理健康专家、病例管理员、社会工作者和药物滥用顾问。

相似文献

1
Care at the Crossroads: Navigating the HIV, HCV, and Substance Abuse Syndemic.十字路口的关怀：应对艾滋病毒、丙型肝炎病毒和药物滥用共病问题
Fed Pract. 2014 Feb;31:37S-40S.
2
Hepatitis C and HIV Coinfection for Social Workers in Public Health, Medical and Substance Use Treatment Settings.面向公共卫生、医疗及物质使用治疗机构社会工作者的丙型肝炎与艾滋病毒合并感染情况
Soc Work Public Health. 2015;30(4):325-35. doi: 10.1080/19371918.2014.1000506. Epub 2015 Mar 26.
3
Risk of Complications After THA Increases Among Patients Who Are Coinfected With HIV and Hepatitis C.感染HIV和丙型肝炎的患者全髋关节置换术后并发症风险增加。
Clin Orthop Relat Res. 2018 Feb;476(2):356-369. doi: 10.1007/s11999.0000000000000025.
4
Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort].人类免疫缺陷病毒（HIV）/丙型肝炎病毒（HCV）合并感染患者的精神障碍和物质使用障碍：HCV清除是否重要？[法国国家艾滋病和病毒性肝炎研究机构（ANRS）HEPAVIH CO13队列研究]
HIV Med. 2016 Nov;17(10):758-765. doi: 10.1111/hiv.12382.
5
Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users coinfected with HIV and HCV.为同时感染艾滋病毒和丙型肝炎病毒的注射吸毒者整合丙型肝炎病毒（HCV）护理和艾滋病毒初级护理。
Clin Infect Dis. 2005 Jul 1;41 Suppl 1:S83-8. doi: 10.1086/429502.
6
Natural history of HIV and HCV coinfection.HIV与HCV合并感染的自然史。
J Int Assoc Physicians AIDS Care (Chic). 2003 Oct-Dec;2(4):147-51.
7
Obstacles to successful HCV treatment in substance addicted patients.药物成瘾患者成功治疗丙型肝炎病毒的障碍。
J Addict Dis. 2008;27(2):61-8. doi: 10.1300/J069v27n02_07.
8
Syndemic profiles of people living with hepatitis C virus using population-level latent class analysis to optimize health services.使用基于人群的潜在类别分析为丙型肝炎病毒感染者制定综合疾病谱，以优化卫生服务。
Int J Infect Dis. 2020 Nov;100:27-33. doi: 10.1016/j.ijid.2020.08.035. Epub 2020 Aug 15.
9
Identifying Barriers to the Treatment of Chronic Hepatitis C Infection.确定慢性丙型肝炎感染治疗的障碍。
Dig Dis. 2020;38(1):46-52. doi: 10.1159/000501821. Epub 2019 Aug 16.
10
The syndemic effect of HIV/HCV co-infection and mental health disorders on acute care hospitalization rate among people living with HIV/AIDS: a population-based retrospective cohort study.HIV/HCV 合并感染和精神健康障碍对 HIV/AIDS 患者急性护理住院率的综合征影响：一项基于人群的回顾性队列研究。
Can J Public Health. 2019 Dec;110(6):779-791. doi: 10.17269/s41997-019-00253-w. Epub 2019 Aug 22.

引用本文的文献

1
Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial.将 HCV 检测与 HIV 项目相结合可改善注射吸毒人群的丙型肝炎结局：一项集群随机试验。
J Hepatol. 2020 Jan;72(1):67-74. doi: 10.1016/j.jhep.2019.09.022. Epub 2019 Oct 8.
2
Integration of care for HIV and opioid use disorder.艾滋病病毒和阿片类药物使用障碍的综合护理。
AIDS. 2019 Apr 1;33(5):873-884. doi: 10.1097/QAD.0000000000002125.
3
Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?阿片类物质使用障碍患者的综合护理模式：我们如何预防 HIV 和 HCV？
Curr HIV/AIDS Rep. 2018 Jun;15(3):266-275. doi: 10.1007/s11904-018-0396-x.
4
Mobile technology intervention to improve care coordination between HIV and substance use treatment providers: development, training, and evaluation protocol.移动技术干预以改善艾滋病毒与药物使用治疗提供者之间的护理协调：开发、培训和评估方案。
Addict Sci Clin Pract. 2017 Mar 14;12(1):8. doi: 10.1186/s13722-017-0073-1.

本文引用的文献

1
A Qualitative Study of Barriers to the Utilization of HIV Testing Services Among Rural African American Cocaine Users.一项关于美国农村非裔可卡因使用者中艾滋病毒检测服务利用障碍的定性研究。
J Drug Issues. 2013 Jul;43(3):314-334. doi: 10.1177/0022042613476260.
2
Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis.治疗活跃性注射毒品人群中的丙型肝炎病毒感染：系统评价和荟萃分析。
Clin Infect Dis. 2013 Aug;57 Suppl 2:S80-9. doi: 10.1093/cid/cit306.
3
Recommendations for the management of hepatitis C virus infection among people who inject drugs.建议对注射吸毒者中的丙型肝炎病毒感染者进行管理。
Clin Infect Dis. 2013 Aug;57 Suppl 2:S129-37. doi: 10.1093/cid/cit302.
4
Management of hepatitis C virus/HIV coinfection among people who use drugs in the era of direct-acting antiviral-based therapy.直接作用抗病毒药物治疗时代的吸毒人群丙型肝炎病毒/人类免疫缺陷病毒合并感染的管理。
Clin Infect Dis. 2013 Aug;57 Suppl 2(Suppl 2):S118-24. doi: 10.1093/cid/cit326.
5
Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial.Boceprevir 联合聚乙二醇干扰素 α-2b 和利巴韦林与安慰剂联合聚乙二醇干扰素 α-2b 和利巴韦林治疗 HIV 合并 HCV 基因 1 型感染：一项随机、双盲、对照的 2 期临床试验。
Lancet Infect Dis. 2013 Jul;13(7):597-605. doi: 10.1016/S1473-3099(13)70149-X. Epub 2013 Jun 12.
6
Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial.替拉瑞韦联合治疗方案治疗 HIV 合并慢性丙型肝炎病毒 1 型感染：一项随机试验。
Ann Intern Med. 2013 Jul 16;159(2):86-96. doi: 10.7326/0003-4819-159-2-201307160-00654.
7
Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV.成人 HIV/HCV 合并感染患者的肝病分期和抗病毒治疗与肝脏相关事件和死亡的关系。
JAMA. 2012 Jul 25;308(4):370-8. doi: 10.1001/jama.2012.7844.
8
HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment.HIV 和丙型肝炎病毒合并感染的吸毒者：新的直接作用抗病毒药物对丙型肝炎病毒治疗的影响。
Curr Opin HIV AIDS. 2012 Jul;7(4):339-44. doi: 10.1097/COH.0b013e328354131e.
9
Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers.为注射吸毒者延迟抗逆转录病毒治疗的提供者和诊所相关因素：对北美 HIV 提供者的调查。
J Int AIDS Soc. 2012 Feb 23;15(1):10. doi: 10.1186/1758-2652-15-10.
10
Injection drug users' perspectives on placing HIV prevention and other clinical services in pharmacy settings.注射吸毒者对在药房环境中提供 HIV 预防和其他临床服务的看法。
J Urban Health. 2012 Apr;89(2):354-64. doi: 10.1007/s11524-011-9651-9.